Literature DB >> 2317853

Analysis of risk factors for restenosis after PTCA.

H J Rupprecht1, R Brennecke, G Bernhard, R Erbel, T Pop, J Meyer.   

Abstract

To identify risk factors for restenosis, we evaluated data in 473 patients with single-vessel percutaneous transluminal coronary angioplasty (PTCA) and control angiography after 6 months. Restenosis, defined as (1) loss greater than 50% of the initial gain, and (2) stenosis greater than 50% was found in 138 patients (29.2%). Univariate analysis revealed eight factors related to restenosis: (1) duration of symptoms less than 1 month (P = 0.005), (2) unstable angina (P = 0.004), (3) high-grade stenosis before PTCA (P = 0.014), (4) large residual stenosis after PTCA (P = 0.001), (5) insufficient improvement of stenosis (P = 0.042), (6) prolonged single inflation time (P = 0.017), (7) prolonged total inflation time (P = 0.055), and (8) low inflation pressure (P = 0.028). Multivariate analysis revealed four factors significantly related to restenosis: (1) large residual stenosis after PTCA (P = 0.0001), (2) prolonged single inflation time (P = 0.0047), (3) unstable angina (P = 0.0127), and (4) high-grade stenosis before PTCA (P = 0.0179). Modification of procedural factors might be helpful to reduce the risk of restenosis after successful PTCA.

Entities:  

Mesh:

Year:  1990        PMID: 2317853     DOI: 10.1002/ccd.1810190302

Source DB:  PubMed          Journal:  Cathet Cardiovasc Diagn        ISSN: 0098-6569


  8 in total

Review 1.  Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part II).

Authors:  J P Herrman; W R Hermans; J Vos; P W Serruys
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

2.  A comparative study of restenosis rates in bare metal and drug-eluting stents.

Authors:  Shilpi Mohan; Anil Dhall
Journal:  Int J Angiol       Date:  2010

3.  Uncomplicated moderate coronary artery dissections after balloon angioplasty: good outcome without stenting.

Authors:  M Albertal; G Van Langenhove; E Regar; I P Kay; D Foley; G Sianos; K Kozuma; T Beijsterveldt; S G Carlier; J A Belardi; E Boersma; J E Sousa; B de Bruyne; P W Serruys
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

4.  [Clinical follow-up 6 months after ambulatory/partial inpatient after-care rehabilitation. Further results of the Cologne model of ambulatory cardiac phase II rehabilitation].

Authors:  B Bjarnason-Wehrens; H G Predel; C Graf; R Rost
Journal:  Herz       Date:  1999-04       Impact factor: 1.443

5.  Vitamin D attenuates HMGB1-mediated neointimal hyperplasia after percutaneous coronary intervention in swine.

Authors:  Mohan Satish; Palanikumar Gunasekar; Juan A Asensio; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2020-08-01       Impact factor: 3.396

Review 6.  Thrombin and antithrombotic therapy in interventional cardiology.

Authors:  J P Herrman; P W Serruys
Journal:  Tex Heart Inst J       Date:  1994

7.  Vitamin D Supplementation Reduces Intimal Hyperplasia and Restenosis following Coronary Intervention in Atherosclerotic Swine.

Authors:  Gaurav K Gupta; Tanupriya Agrawal; Vikrant Rai; Michael G Del Core; William J Hunter; Devendra K Agrawal
Journal:  PLoS One       Date:  2016-06-06       Impact factor: 3.240

8.  Evaluation of relationship between common carotid artery intima-media thickness and coronary in-stent restenosis: A case-control study.

Authors:  Penta Bhavanadhar; Yerrabandi Venkata Subba Reddy; Adikeshava Naidu Otikunta; Ravi Srinivas
Journal:  Interv Med Appl Sci       Date:  2018-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.